ASPI
ASP Isotopes·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 0
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ASPI
Asp Isotopes Inc.
A leading manufacturer of specialty isotopes and chemicals for medical, industrial, and research applications
2200 Ross Avenue, Suite 4575E, Dallas, TX 75201
--
ASP Isotops Inc., was incorporated in Delaware on September 13, 2021. The company is an advanced material development company that focuses on enriching natural isotopes into higher concentration products for use in various industries. Using its proprietary aerodynamic separation process and quantum enrichment technology, ASP Isotops' initial goal is to produce concentrated carbon-14, silicon-28 and yttrium-176. The company has started commercial production at its facility in South Africa and is also pursuing a uranium enrichment initiative for advanced nuclear fuel.
Company Financials
EPS
ASPI has released its 2025 Q3 earnings. EPS was reported at -0.15, versus the expected -0.02, missing expectations. The chart below visualizes how ASPI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ASPI has released its 2025 Q3 earnings report, with revenue of 4.89M, reflecting a YoY change of 349.53%, and net profit of -12.89M, showing a YoY change of -75.29%. The Sankey diagram below clearly presents ASPI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
